A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

This week I’m not presenting my opinion. Although when I was aware of these reports and testimonies after COVID, they did inform my opinion and still do. These are excerpts from sworn testimony given ...

U.S. lawmakers are pushing forward with a probe into a pandemic-era political controversy centered around the timing of COVID-19 vaccine trial results.

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until after the 2020 election ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating that additional data is still required.

Pfizer said its vaccine was 95% effective following its Phase 3 trial, but Texas' attorney general said the data was too premature.

Embattled Texas Attorney General Ken Paxton is suing Pfizer, claiming the company unlawfully misrepresented the effectiveness of its COVID-19 vaccine and tried to censor public discussion of the ...

FDA staff said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.

The U.S. health regulator's staff reviewers said on Tuesday data from Pfizer Inc's COVID-19 drug trials support its use in adults at high risk of progressing to severe disease, bringing the pill ...